Tech Company Financing Transactions

Torigen Pharma Funding Round

Torigen Pharma secured a $13 million Series A investment round on 11/16/2022. Investors included Connecticut Innovations, Werth Family Investment Associates and Advantage Capital Partners.

Transaction Overview

Company Name
Announced On
11/16/2022
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series A
Proceeds Purpose
This round of funding will allow us to continue to develop new products and leverage our pipeline. We are excited to work with all our investors as we expand our platform and continue to help the millions of pets diagnosed with cancer and other immune-mediated diseases each year.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Farmington Avenue R1855 CB129
Farmington,, CT 06032
USA
Phone
Undisclosed
Email Address
Overview
Torigen Pharmaceuticals is focused on veterinary cancer care. Our product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment which educates the immune system to recognize the tumor as foreign. With over 12 years of supporting research, VetiVax allows for a variety of tumor antigens to be presented to the immune system. This abundant choice increases the likelihood of a successful response.
Profile
Torigen Pharma LinkedIn Company Profile
Social Media
Torigen Pharma Company Twitter Account
Company News
Torigen Pharma News
Facebook
Torigen Pharma on Facebook
YouTube
Torigen Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ashley Kalinauskas
  Ashley Kalinauskas LinkedIn Profile  Ashley Kalinauskas Twitter Account  Ashley Kalinauskas News  Ashley Kalinauskas on Facebook
Chief Financial Officer
John Kallassy
  John Kallassy LinkedIn Profile  John Kallassy Twitter Account  John Kallassy News  John Kallassy on Facebook
Chief Medical Officer
Michael Lucroy
  Michael Lucroy LinkedIn Profile  Michael Lucroy Twitter Account  Michael Lucroy News  Michael Lucroy on Facebook
Chief Technical Officer
Mark Suckow
  Mark Suckow LinkedIn Profile  Mark Suckow Twitter Account  Mark Suckow News  Mark Suckow on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/16/2022: Pure Electric venture capital transaction
Next: 11/16/2022: Valcre venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary